Paramedic Drug Reference Study Guide

Preface and Manual Scope

  • Welcome Message: Presented by the instructors and administrative team for The School of EMS.
  • Intended Use:
    • Designed as a tool for educational goals.
    • Access to common pre-hospital medications focusing on field treatment and dosing.
    • Not intended to replace existing agency protocols; serves as an educational guide.
  • Content: Includes industry-standard recommendations for medications used during transport.
  • Organization: Alphabetical order, designed for mobile referencing.
  • Patient Care Philosophy: Emphasizes frontline emergency care excellence for world-class patient treatment.

ACETAMINOPHEN (Tylenol, Ofrimev)

  • Class: Analgesic and anti-pyretic.
  • Mechanism of Action:
    • Exact mechanism is not known.
    • May reduce the production of prostaglandins in the brain (chemicals causing inflammation and swelling).
    • Elevates the pain threshold to relieve pain.
    • Reduces fever by acting on the heat-regulating center of the brain to lower elevated body temperature.
  • Indications: Treatment of fever and pain.
  • Contraindications:
    • Allergy to the medication.
    • Severe liver disease.
  • Dosage and Administration:
    • Adult PO: 650−1000 mg650-1000\,mg PO every 4 hrs4\,hrs; daily maximum is 3000 mg3000\,mg.
    • Adult IV: 650−1000 mg650-1000\,mg IV.
    • Pediatric: 15 mg/kg15\,mg/kg PO or PR every 4 hrs4\,hrs.
  • Duration of Action:
    • Onset: 30−45 minutes30-45\,minutes.
    • Peak Effect: 30−60 minutes30-60\,minutes.
    • Duration: 4−6 hrs4-6\,hrs.
  • Special Considerations: Avoid in patients with severe liver disease.

ACETYLCYSTEINE (Mucomyst, Acetadote)

  • Class: Acetaminophen antidote.
  • Mechanism of Action: Restores glutathione concentrations within the liver. Glutathione is an antioxidant used for detoxifying substances.
  • Indications: Acetaminophen overdose.
  • Contraindications: Known hypersensitivity, acute asthma.
  • Adverse Reactions/Side Effects: Urticaria, flushing, rash, angioedema, nausea.
  • Drug Interactions: Nitroglycerin.
  • Dosage and Administration (Adult and Pediatric):
    • Loading Dose: 150 mg/kg150\,mg/kg IV mixed in 200 mL200\,mL of D5WD5W; infuse over 1 hour1\,hour.
    • Maintenance Dose: 50 mg/kg50\,mg/kg IV in 500 mL500\,mL of D5WD5W; infuse over 4 hours4\,hours.
    • Oral Alternative: If IV access is unavailable, give 140 mg/kg140\,mg/kg orally.
  • Duration of Action:
    • Onset: 1 minute1\,minute.
    • Peak Effect: 5−15 minutes5-15\,minutes.
    • Duration: 100 minutes100\,minutes.
  • Special Considerations:
    • Pregnancy Safety: Category B.
    • Anaphylactoid-type reactions usually follow the first dose; can be minimized by insuring the infusion takes a full 1 hour1\,hour.

ACTIVATED CHARCOAL

  • Class: Adsorbent.
  • Mechanism of Action: Adsorbs toxic substances from the GI tract.
  • Indications: Most oral poisonings and medication overdoses; can be used after evacuation of poisons.
  • Contraindications:
    • Oral administration to comatose patients.
    • Ingestion of corrosives, caustics, or petroleum distillates (ineffective and may induce vomiting).
    • Simultaneous administration with other oral drugs.
  • Adverse Reactions: May induce nausea and vomiting; may cause constipation and black stools.
  • Drug Interactions: Bonds with and inactivates items it is mixed with (e.g., syrup of ipecac).
  • Dosage and Administration:
    • Adult: 1−2 gm/kg1-2\,gm/kg PO or via Nasogastric Tube (NGT).
    • Pediatric: 1−2 gm/kg1-2\,gm/kg PO or via NGT.
  • Duration of Action: Acts until excreted; depends on GI function.
  • Special Considerations:
    • Often used with magnesium citrate.
    • Must be stored in a closed container.
    • Does not adsorb cyanide, lithium, iron, lead, and arsenic.

ADENOSINE (Adenocard)

  • Class: Endogenous Nucleotide.
  • Mechanism of Action:
    • Slows conduction time through the AV Node.
    • Can interrupt re-entrant pathways.
    • Slows heart rate; acts directly on sinus pacemaker cells.
    • Drug of choice for PSVT.
  • Indications: Conversion of PSVT to sinus rhythm; may convert PSVT in Wolff-Parkinson-White syndrome.
  • Non-Indications: Not effective for converting atrial fibrillation or atrial flutter.
  • Contraindications:
    • Second or third-degree heart block.
    • Sick Sinus Syndrome.
    • Atrial flutter / Atrial fibrillation.
    • Ventricular Tachycardia.
    • Hypersensitivity to adenosine.
  • Adverse Reactions: Facial flushing, shortness of breath, chest pain, headache, paresthesia, diaphoresis, palpitations, hypotension, nausea, metallic taste.
  • Drug Interactions:
    • Methylxanthines (e.g., theophylline) antagonize the effects.
    • Dipyridamole (Persantine) potentiates the effects.
    • Carbamazepine (Tegretol) may potentiate AV Node blocking effects.
  • Dosage and Administration:
    • Adult: 6 mg6\,mg rapid IV over 1−3 seconds1-3\,seconds. If no response in 1−2 minutes1-2\,minutes, administer 12 mg12\,mg over 1−3 seconds1-3\,seconds. Maximum total dose = 18 mg18\,mg.
    • Pediatric: 0.1 mg/kg0.1\,mg/kg rapid IV. If no response in 1−2 minutes1-2\,minutes, administer 0.2 mg/kg0.2\,mg/kg over 1−3 seconds1-3\,seconds. Maximum single dose = 12 mg12\,mg; maximum total dose = 18 mg18\,mg.
  • Duration of Action:
    • Onset and peak in seconds.
    • Duration: 12 seconds12\,seconds.
  • Special Considerations:
    • Short half-life limits side effects.
    • Pregnancy Safety: Category C.

ALBUTEROL (Proventil, Ventolin)

  • Class: Sympathomimetic, bronchodilator.
  • Mechanism of Action: Selective β−2\beta-2 agonist; stimulates adrenergic receptors resulting in smooth muscle relaxation in the bronchial tree and peripheral vasculature.
  • Indications: Treatment of bronchospasm in patients with reversible obstructive airway disease (COPD/asthma).
  • Contraindications:
    • Known prior hypersensitivity.
    • Tachycardia and dysrhythmias, especially those caused by digitalis.
    • Synergistic with other sympathomimetics.
  • Adverse Reactions: Dose-related. Includes restlessness, tremors, dizziness, palpitations, tachycardia, nervousness, peripheral vasodilatation, nausea, vomiting, hyperglycemia, increased BP, and paradoxical bronchospasm.
  • Drug Interactions:
    • Tricyclic antidepressants may potentiate vasculature effects.
    • Beta-blockers are antagonistic.
    • May potentiate hypokalemia caused by diuretics.
  • Dosage and Administration:
    • Adult: Administer 2.5 mg2.5\,mg. Dilute 0.5 ml0.5\,ml of 0.5%0.5\% solution with 2.5 ml2.5\,ml normal saline in a nebulizer over 10−15 minutes10-15\,minutes.
    • Pediatric: 2.5 mg2.5\,mg in 6 mL6\,mL NS.
  • Duration of Action:
    • Onset: 5−15 minutes5-15\,minutes.
    • Peak effect: 30 minutes30\,minutes to 2 hours2\,hours.
    • Duration: 3−4 hours3-4\,hours.
  • Special Considerations:
    • Only for inhalation methodology in pre-hospital management.
    • Pregnancy Safety: Category C.
    • May precipitate angina pectoris and dysrhythmias.

AMIODARONE (Cordarone)

  • Class: Antidysrhythmic.
  • Mechanism of Action:
    • Prolongation of action potential.
    • Non-competitive alpha and beta sympathetic blocking effects.
    • Calcium channel blocking effects.
  • Indications:
    • Suppression of VF / Pulseless VT refractory to defibrillation.
    • Suppression of VT with a pulse.
  • Contraindications:
    • Allergy to Iodine.
    • Medication-induced ventricular dysrhythmias.
    • Torsades de Pointes.
  • Adverse Reactions: Hypotension, bradycardia, PEA, CHF, nausea, fever.
  • Drug Interactions: Incompatible with Sodium Bicarbonate (will precipitate).
  • Dosage and Administration:
    • Adult VF/Pulseless VT: 300 mg300\,mg IV Push in 14 ml14\,ml NS. Repeat dose: 150 mg150\,mg in 7 ml7\,ml NS.
    • Adult VT with a Pulse: 150 mg150\,mg in 100 mL100\,mL NS infused over 10 minutes10\,minutes.
    • Pediatric: 5 mg/kg5\,mg/kg slow IV Push over 1−2 minutes1-2\,minutes in 10 ml10\,ml NS.
  • Duration of Action:
    • Onset: Within 5−15 minutes5-15\,minutes.
    • Peak Effect: Variable.
    • Duration: Variable.
  • Special Considerations:
    • Pregnancy Safety: Category C.
    • Administer cautiously in patients with Heart Failure or poor systolic function.

CYANIDE ANTIDOTE KIT (Amyl Nitrite, Sodium Nitrite, Sodium Thiosulfate)

  • Class: Antidote.
  • Mechanism of Action:
    • Amyl Nitrite: Affinity for cyanide ions; reacts with hemoglobin to form methemoglobin (low toxicity).
    • Sodium Nitrite: Same mechanism as amyl nitrite.
    • Sodium Thiosulfate: Produces thiocyanate, which is excreted.
  • Indications: Cyanide or hydrocyanic acid poisoning.
  • Contraindications: Not applicable.
  • Adverse Reactions: Excessive doses of nitrites can produce life-threatening methemoglobinemia; use only recommended doses.
  • Dosage and Administration (Adult and Pediatric):
    • Amyl Nitrite: Inhaled/breathed 30 seconds30\,seconds out of every minute.
    • Sodium Nitrite and Thiosulfate: IV per instructions in the antidote kit.
  • Special Considerations:
    • Poisoning must be treated quickly; prognosis is good if pulse persists (even with apnea).
    • Must be used in conjunction with oxygen administration.

ASPIRIN

  • Class: Platelet inhibitor, anti-inflammatory agent.
  • Mechanism of Action: Prostaglandin inhibition (makes platelets less sticky).
  • Indications: Chest pain suggestive of Acute Myocardial Infarction.
  • Contraindications: Hypersensitivity, GI bleeding, signs of recent CVA.
  • Adverse Reactions: Heartburn, GI bleeding, nausea, vomiting, wheezing (in allergic patients), prolonged bleeding.
  • Drug Interactions: Use caution in patients allergic to NSAIDs.
  • Dosage and Administration: 162 mg162\,mg to 324 mg324\,mg PO.
  • Duration of Action:
    • Onset: 30−45 minutes30-45\,minutes.
  • Special Considerations: Pregnancy Safety: Category D. Not recommended in the pediatric population.

ATROPINE SULFATE

  • Class: Anticholinergic agent.
  • Mechanism of Action:
    • Increases heart rate in life-threatening bradydysrhythmias.
    • Increases conduction through the AV Node.
    • Parasympatholytic: Inhibits acetylcholine at postganglionic parasympathetic neuroeffector sites.
  • Indications: Hemodynamically significant bradycardia; drug of choice for organophosphate poisoning.
  • Contraindications: Tachycardia, hypersensitivity, unstable cardiovascular status in hemorrhage or ischemia.
  • Adverse Reactions: Headache, dizziness, palpitations, nausea, vomiting, tachycardia, dysrhythmias, dry mouth, blurred vision, urinary retention, flushed hot skin. Paradoxical bradycardia occurs if pushed too slowly or at low doses.
  • Drug Interactions: Effects enhanced by antihistamines, antipsychotics, benzodiazepines, and antidepressants.
  • Dosage and Administration:
    • Adult Bradycardia: 1 mg1\,mg IV every 3−5 minutes3-5\,minutes to a maximum total dose of 3 mg3\,mg.
    • Pediatric Bradycardia: 0.02 mg/kg0.02\,mg/kg IV/ET/IO (minimum single dose 0.1 mg0.1\,mg, maximum single dose 1.0 mg1.0\,mg).
  • Duration of Action:
    • Onset: Immediate.
    • Peak effect: 1−2 minutes1-2\,minutes.
    • Duration: 2−6 hours2-6\,hours.
  • Special Considerations: Moderate doses dilate pupils. Pregnancy Safety: Category C.

BENZOCAINE SPRAY (Hurricane)

  • Class: Topical anesthetic.
  • Mechanism of Action: Prevents impulse transmission along sensory nerve fibers and nerve endings.
  • Indications: Topical anesthesia; suppresses pharyngeal and tracheal gag reflex.
  • Contraindications: Hypersensitivity.
  • Adverse Reactions: Signs of methemoglobinemia (headache, shortness of breath, anxiety, tachycardia).
  • Drug Interactions: Rare cases of methemoglobinemia. Nitrates/Nitrites may induce formation.
  • Dosage and Administration:
    • Adult: 0.50.5 to 1 second1\,second spray; repeat as needed.
    • Pediatric: 0.250.25 to 0.5 second0.5\,second spray; repeat as needed.
  • Duration of Action:
    • Onset: Immediate.
    • Peak Effect: Less than 5 minutes5\,minutes.
    • Duration: 15−20 minutes15-20\,minutes.
  • Special Considerations: Quantity per spray varies by manufacturer. Potentially dangerous for mouth and throat. Pregnancy Safety: Category C.

BUMETANIDE (Bumex)

  • Class: Loop diuretic.
  • Mechanism of Action: Inhibits reabsorption of sodium and chloride in the ascending limb of the loop of Henle.
  • Indications: Pulmonary edema, heart failure.
  • Contraindications: Hypersensitivity to bumetanide, furosemide, or sulfonamides. Hypovolemia, anuria, electrolyte imbalance, hepatic coma.
  • Adverse Reactions: Dehydration, dizziness, hypotension, ECG changes (electrolyte depletion), itching, fatigue.
  • Drug Interactions: NSAIDs reduce effects; antihypertensives cause further hypotension; increases risk of lithium poisoning.
  • Dosage and Administration:
    • Adult: 0.50.5 to 1 mg1\,mg IV slowly over 1−2 minutes1-2\,minutes or IM.
    • Pediatric: Not recommended for children under 12 years12\,years.
  • Duration of Action:
    • Onset: Immediate.
    • Peak Effect: 15−30 minutes15-30\,minutes.
    • Duration: 3−6 hours3-6\,hours.
  • Special Considerations: Potency is 40 times40\,times greater than Furosemide. Does not have Furosemide's vasodilatory effects. Pregnancy Safety: Category C.

CALCIUM CHLORIDE / CALCIUM GLUCONATE

  • Class: Electrolyte.
  • Mechanism of Action: Increases cardiac contractile state (positive inotrope); enhances ventricular automaticity; stabilizes cell membranes.
  • Indications: Hyperkalemia, Magnesium sulfate overdose, Calcium channel blocker toxicity, Crush syndrome.
  • Contraindications: Hypercalcemia, VF during resuscitation, digitalis toxicity.
  • Adverse Reactions: Bradycardia, asystole, hypotension, metallic taste, local necrosis, coronary/cerebral artery spasm, nausea.
  • Drug Interactions:
    • Do not mix with Sodium Bicarbonate (flush IV line between uses).
    • May worsen digitalis-induced dysrhythmias.
    • May antagonize Verapamil.
  • Dosage and Administration:
    • Adult: 500−1000 mg500-1000\,mg of 10%10\% solution slowly IV over 5 minutes5\,minutes. Max dose 1 gm1\,gm. Repeat in 10 minutes10\,minutes if needed.
    • Pediatric: 20 mg/kg20\,mg/kg of 10%10\% solution slow IV/IO. Max dose 1 gm1\,gm.
  • Duration of Action:
    • Onset: 5−15 minutes5-15\,minutes.
    • Peak Effect: 3−5 minutes3-5\,minutes.
    • Duration: 15−30 minutes15-30\,minutes (up to 4 hours4\,hours dose-dependent).
  • Special Considerations: For pediatrics, if gluconate is unavailable, substitute 1−2 ml1-2\,ml of 10%10\% chloride solution diluted with IV fluid.

CIMETIDINE (Tagamet)

  • Class: Antiulcer, H2 blocker.
  • Mechanism of Action: Blocks histamine at H2 receptors of gastric parietal cells.
  • Indications: Gastric or duodenal ulcers, GERD, adjunct for hives/itching.
  • Contraindications: Hypersensitivity to cimetidine or other H2 blockers.
  • Adverse Reactions: Headache, dizziness, diarrhea, muscle aches.
  • Drug Interactions: Inhibits liver enzymes; may increase plasma levels of certain drugs.
  • Dosage and Administration:
    • Adult: 400 mg400\,mg PO four times daily. Max 1200 mg/day1200\,mg/day.
    • Pediatric: Not recommended, but used as 20−40 mg/kg/day20-40\,mg/kg/day in divided doses.
  • Duration of Action:
    • Onset: 60 minutes60\,minutes.
    • Duration: 4−5 hours4-5\,hours.
  • Special Considerations: Pregnancy Safety: Category B.

DEXAMETHASONE (Decadron)

  • Class: Corticosteroid.
  • Mechanism of Action: Suppresses inflammation; immunosuppressive effects.
  • Indications: Anaphylaxis, asthma, spinal cord injury, croup, elevated ICP, adjunct for shock.
  • Contraindications: Hypersensitivity.
  • Adverse Reactions: Hypertension, sodium/water retention, GI bleeding. Single doses typically produce no reactions.
  • Dosage and Administration:
    • Adult: 10−100 mg10-100\,mg IV (1 mg/kg1\,mg/kg slow IV bolus).
    • Pediatric: 0.25−1.0 mg/kg0.25-1.0\,mg/kg IV/IO/IM.
  • Duration of Action:
    • Onset: Hours.
    • Peak effect: 8−12 hours8-12\,hours.
    • Duration: 24−72 hours24-72\,hours.
  • Special Considerations: Protect from heat. Toxicity with long-term use.

DEXTROSE

  • Class: Carbohydrate, hypertonic solution.
  • Mechanism of Action: Rapidly increases serum glucose levels.
  • Indications: Altered consciousness due to hypoglycemia.
  • Contraindications: Intracranial hemorrhage, delirium tremens.
  • Adverse Reactions: Tissue necrosis from extravasation; warmth, burning, thrombophlebitis.
  • Dosage and Administration:
    • Adult: 12.5−25 grams12.5-25\,grams slow IV.
    • Pediatric: 0.5−1 gram/kg0.5-1\,gram/kg slow IV.
  • Duration of Action: Onset under 1 minute1\,minute.
  • Special Considerations: Draw blood sugar before administration. Do not give to suspected CVA patients unless hypoglycemia is documented.

DIAZEPAM (Valium)

  • Class: Benzodiazepine, anticonvulsant, sedative-hypnotic.
  • Mechanism of Action: Potentiates inhibitory neurotransmitters; raises seizure threshold; induces sedation and amnesia.
  • Indications: Status Seizure, acute anxiety, analgesia for medical procedures (e.g., cardioversion, fracture reduction), delirium tremens.
  • Contraindications: Glaucoma, coma, shock, head injury, substance abuse.
  • Adverse Reactions: Respiratory depression, hypotension, drowsiness, reflex tachycardia.
  • Dosage and Administration:
    • Adult Seizure: 5−10 mg5-10\,mg IV every 10−15 minutes10-15\,minutes as needed (5 mg5\,mg over 5 min5\,min). Max 30 mg30\,mg.
    • Pediatric Seizure: 0.2 mg/kg0.2\,mg/kg IV every 15−30 minutes15-30\,minutes (max 10 mg10\,mg).
    • Rectal Dosage: 0.5 mg/kg0.5\,mg/kg via 2"2" rectal catheter; flush with 2−3 ml2-3\,ml air.
    • Cardioversion Sedation: 5−15 mg5-15\,mg IV over 5−10 minutes5-10\,minutes prior to procedure.
  • Duration of Action: Onset 1−5 minutes1-5\,minutes; Duration 20−50 minutes20-50\,minutes.
  • Special Considerations: Pregnancy Safety: Category D. Reduce dose 50%50\% in elderly.

DILTIAZEM HCL (Cardizem)

  • Class: Calcium channel blocker.
  • Mechanism of Action: Blocks calcium ion influx into cardiac muscle; arterial/venous vasodilator; reduces preload, afterload, and myocardial oxygen demand.
  • Indications: Atrial flutter or fibrillation with rapid ventricular rates.
  • Contraindications: Wide-complex tachycardia, sick sinus syndrome, cardiogenic shock.
  • Adverse Reactions: Bradycardia, AV blocks, chest pain, syncope, V-fib, nausea, dry mouth.
  • Dosage and Administration:
    • Adult Initial: 0.25 mg/kg0.25\,mg/kg (avg 20 mg20\,mg) IV over 2 minutes2\,minutes.
    • Adult Re-bolus: 0.35 mg/kg0.35\,mg/kg IV over 2 minutes2\,minutes after 15 minutes15\,minutes if needed.
  • Duration of Action: Onset 2−5 minutes2-5\,minutes; Duration 1−3 hours1-3\,hours.

DIPHENHYDRAMINE (Benadryl)

  • Class: Antihistamine.
  • Mechanism of Action: Blocks cellular histamine receptors; decreases vasodilation; reverses extrapyramidal reactions.
  • Indications: Symptomatic relief of allergies, anaphylaxis, acute dystonic reactions (phenothiazines), blood administration reactions.
  • Contraindications: Asthma, glaucoma, pregnancy, infants.
  • Adverse Reactions: Sedation, hypotension, seizures, dry mouth, paradoxical CNS excitation in children.
  • Dosage and Administration:
    • Adult: 25−50 mg25-50\,mg IM, IV, or PO.
    • Pediatric: 1−2 mg/kg1-2\,mg/kg IV/IO slowly or IM.
  • Duration of Action: Onset 15−30 minutes15-30\,minutes; Duration 3−12 hours3-12\,hours.

DOBUTAMINE HYDROCHLORIDE (Dobutrex)

  • Class: Adrenergic, inotropic agent.
  • Mechanism of Action: Synthetic catecholamine; stimulates β−1\beta-1 receptors (minor β−2\beta-2 and α−1\alpha-1); increases contractility and stroke volume.
  • Indications: Heart failure with SBP 70−100 mm Hg70-100\,mm\,Hg and no signs of shock.
  • Contraindications: Hypersensitivity, poison/drug-induced shock, SBP under 70 mm Hg70\,mm\,Hg, idiopathic hypertrophic subaortic stenosis.
  • Dosage and Administration:
    • Adult/Pediatric: IV infusion at 2−20 mcg/kg/min2-20\,mcg/kg/min titrated to effect.
  • Special Considerations: Monitor BP/hemodynamics; titrate to maintain HR increase under 10%10\% of baseline. Pregnancy Safety: Category B.

DOPAMINE (Inotropin)

  • Class: Sympathomimetic, inotropic agent.
  • Mechanism of Action (Dose Dependent):
    • 2−4 mcg/kg/min2-4\,mcg/kg/min (Dopaminergic): Dilates renal vessels; increases urine output.
    • 4−10 mcg/kg/min4-10\,mcg/kg/min (Beta-adrenergic): Increases chronotropy and inotropy.
    • 10−20 mcg/kg/min10-20\,mcg/kg/min (Adrenergic): Alpha stimulant, vasoconstriction.
    • >20 mcg/kg/min>20\,mcg/kg/min: Reversal of renal effects / overrides alpha.
  • Indications: Shock (cardiogenic, septic, spinal, distributive), hypotension with low cardiac output states.
  • Contraindications: Hypovolemic shock, pheochromocytoma, tachydysrhythmias, VF.
  • Dosage and Administration: 5−20 mcg/kg/min5-20\,mcg/kg/min (rate determined by physician).
  • Special Considerations: Incompatible with alkaline solutions; avoid extravasation.

DROPERIDOL (Inapsine)

  • Class: Antiemetic, antipsychotic.
  • Mechanism of Action: Tranquilization/sedation; reduces motor activity and anxiety; possesses adrenergic blocking and antihistaminic properties.
  • Indications: Chemical restraint, acute delirium, or psychosis.
  • Contraindications: Hypersensitivity, prolonged QT interval; use caution in cardiac disease or Class I/III antidysrhythmic use.
  • Adverse Reactions: QT interval prolongation, VT, Torsades de Pointes (TdP), hypertension, hallucinations, extrapyramidal symptoms.
  • Dosage and Administration:
    • Adult: 2.5 mg2.5\,mg slow IV or 5 mg5\,mg IM.
  • Special Considerations: Monitor vital signs and ECG for QT prolongation. Pregnancy Safety: Category C.

EPINEPHRINE

  • Class: Sympathomimetic.
  • Mechanism of Action:
    • Alpha: Vasoconstriction.
    • B1B1: Positive inotrope/chronotrope.
    • B2B2: Bronchial smooth muscle relaxation.
    • General: Blocks histamine release.
  • Indications: Cardiac arrest (Asystole, PEA, VF), severe bronchospasm, anaphylaxis.
  • Contraindications: Hypertension, hypothermia, pulmonary edema, hypovolemic shock.
  • Dosage and Administration:
    • Adult Allergic/Asthma: 0.3−0.5 mg0.3-0.5\,mg IM (1:10001:1000).
    • Adult Anaphylaxis: 0.3−0.5 mg0.3-0.5\,mg IV (1:10,0001:10,000).
    • Adult Cardiac: 1 mg1\,mg IV (1:10,0001:10,000) every 3−5 minutes3-5\,minutes.
    • Pediatric Allergic/Asthma: 0.01 mg/kg0.01\,mg/kg IM to maximum 0.5 mg0.5\,mg.
    • Pediatric Cardiac: 0.01 mg/kg0.01\,mg/kg IV/IO (1:10,0001:10,000).
  • Special Considerations: Deactivated by alkaline solutions. Pregnancy Safety: Category C.

ETOMIDATE (Amidate)

  • Class: Nonbarbiturate hypnotic, anesthesia induction agent.
  • Mechanism of Action: Short-acting hypnotic acting at the reticular activating system.
  • Indications: Premedication for RSI.
  • Contraindications: Labor/delivery, septic shock.
  • Adverse Reactions: Apnea, respiratory depression, involuntary muscle movement.
  • Dosage and Administration:
    • Adult: 0.2−0.6 mg/kg0.2-0.6\,mg/kg IV (typical adult dose 20 mg20\,mg).
    • Pediatric (>10 yrs): 0.2−0.4 mg/kg0.2-0.4\,mg/kg IV/IO, one time only, max 20 mg20\,mg.
  • Duration of Action: Onset under 1 minute1\,minute. Duration 5−10 minutes5-10\,minutes.

FAMOTIDINE (Pepcid)

  • Class: Antiulcer, H2 blocker.
  • Mechanism of Action: Inhibits volume and concentration of gastric secretions.
  • Indications: GI ulcer, upper GI bleeding, GERD, adjunct for urticaria/pruritus.
  • Adverse Reactions: Constipation, rhabdomyolysis, seizures, pneumonia, prolonged QT.
  • Drug Interactions: Increased action of metformin; decreased absorption of iron.
  • Dosage and Administration:
    • Adult: 20 mg20\,mg IV or PO twice daily.
    • Pediatric: 0.25 mg/kg0.25\,mg/kg IV (max 20 mg20\,mg); 0.5 mg/kg0.5\,mg/kg PO (max 40 mg40\,mg).
  • Special Considerations: Pregnancy Safety: Category B.

FENTANYL CITRATE (Sublimaze)

  • Class: Narcotic Analgesic.
  • Mechanism of Action: Potent narcotic; 100 mcg100\,mcg is equivalent to 10 mg10\,mg of morphine.
  • Indications: Analgesia, RSI premedication, induction/maintenance of general anesthesia.
  • Adverse Reactions: Respiratory depression, apnea, rigidity, bradycardia, secondary rebound respiratory depression.
  • Dosage and Administration:
    • Adult: 1 mcg/kg1\,mcg/kg to max 150 mcg150\,mcg slow IV push.
    • Pediatric: Safety not established under 2 years2\,years old. Nasal administration may be permitted by state protocol.
  • Duration of Action: Onset immediate; duration 30−60 minutes30-60\,minutes.

FLUMAZENIL (Romazicon)

  • Class: Benzodiazepine receptor antagonist, antidote.
  • Mechanism of Action: Antagonizes actions of benzodiazepines in the CNS; reverses sedation and impairment.
  • Contraindications: TCA overdose, chronic benzodiazepine users/alcoholics, cocaine intoxication, known seizure disorder.
  • Dosage and Administration (Adult):
    • Dose 1: 0.2 mg0.2\,mg IV over 15 sec15\,sec.
    • Dose 2: 0.3 mg0.3\,mg IV over 30 sec30\,sec.
    • Dose 3: 0.5 mg0.5\,mg over 30 sec30\,sec at 1−min1-min intervals up to max 3 mg3\,mg.
  • Special Considerations: Administer in large veins to avoid site pain. Be prepared to manage seizures or withdrawal syndromes.

FUROSEMIDE (Lasix)

  • Class: Loop diuretic.
  • Mechanism of Action: Inhibits electrolyte reabsorption and promotes excretion of Na, K, Cl.
  • Indications: CHF, Pulmonary edema.
  • Contraindications: Hypovolemia, anuria, hypotension (relative).
  • Dosage and Administration:
    • Adult: 0.5−1.0 mg/kg0.5-1.0\,mg/kg slow IV.
    • Pediatric: 1 mg/kg1\,mg/kg IV/IO.
  • Special Considerations: Ototoxicity and deafness can occur. Pregnancy Safety: Category C.

GLUCAGON

  • Class: Hyperglycemic agent, pancreatic hormone.
  • Mechanism of Action: Stimulates glycolysis; stabilizes rhythm in beta-blocker overdose.
  • Indications: Suspected hypoglycemia, inotrope for beta-blocker overdose.
  • Dosage and Administration:
    • Adult: 0.5−1 mg0.5-1\,mg IM, SC, or slow IV.
    • Pediatric: 0.1 mg/kg0.1\,mg/kg (max 1 mg1\,mg).
  • Special Considerations: Ineffective if glycogen stores are depleted.

HALOPERIDOL (Haldol)

  • Class: Tranquilizer, antipsychotic.
  • Mechanism of Action: Strong antidopaminergic; inhibits CNS catecholamine receptors.
  • Indications: Acute psychotic episodes.
  • Contraindications: Parkinson's Disease, agitation from shock/hypoxia.
  • Dosage and Administration: 5 mg5\,mg IM for adults.
  • Special Considerations: Treat haloperidol-induced hypotension with fluids and Norepinephrine (NOT Epinephrine).

HELIUM GAS MIXTURE (Heliox)

  • Class: Medical gas.
  • Mechanism of Action: Reduces airflow resistance in obstructive lung disease.
  • Dosage and Administration:
    • Normoxic: 80%80\% helium / 20%20\% oxygen.
    • Hypoxemic: 70/3070/30 or 60/4060/40 oxygen ratios via nonrebreather reservoir bag.

HEPARIN SODIUM

  • Class: Anticoagulant.
  • Mechanism of Action: Prevents conversion of fibrinogen to fibrin; does not lyse existing clots.
  • Dosage and Administration:
    • Adult Loading: 80 units/kg80\,units/kg IV.
    • Adult Maintenance: 18 units/kg/hour18\,units/kg/hour.
    • Pediatric Loading: 50 u/kg50\,u/kg IV.

HYDRALAZINE (Apresoline)

  • Class: Antihypertensive, vasodilator.
  • Indications: Pregnancy-induced hypertension associate with preeclampsia.
  • Dosage and Administration: 5 mg5\,mg IV; may repeat 10 mg10\,mg after 20 minutes20\,minutes. Goal is map reduction of 20−25%20-25\%.

HYDROCORTISONE/METHYLPREDNISOLONE (Solu-Cortef, Solu-Medrol)

  • Class: Corticosteroid.
  • Dosage and Administration:
    • Hydrocortisone: 2 mg/kg2\,mg/kg IV bolus (max 100 mg100\,mg).
    • Methylprednisolone: 2 mg/kg2\,mg/kg IV bolus (max 125 mg125\,mg).

HYDROXOCOBALAMIN (Vitamin B12)

  • Class: Water soluble Vitamin/Antidote.
  • Mechanism of Action: Binds cyanide ions to form cyanocobalamin, which is excreted in urine.
  • Dosage and Administration (Adult): 5 g5\,g (two 2.5 g2.5\,g vials) infused over 15 min15\,min. A second 5 g5\,g dose may be given (total 10 g10\,g).
  • Reconstitution: Reconstitute each 2.5 g2.5\,g vial with 100 mL100\,mL of diluent (0.9% NaCl0.9\%\,NaCl, LRLR, or D5WD5W). Invert or rock for 30 seconds30\,seconds (do not shake).

HYDROMORPHONE (Dilaudid)

  • Class: Analgesic, opiate agonist.
  • Indications: Moderate to severe pain.
  • Dosage and Administration (Adult): 1−2 mg1-2\,mg SC, IM, or slow IV every 6 hr6\,hr. Titrate to relief.

IBUPROFEN (Advil, Motrin)

  • Class: NSAID, nonopioid analgesic.
  • Dosage and Administration:
    • Adult (>6 months): 10 mg/kg10\,mg/kg PO. Max 800 mg800\,mg.
    • Pediatric (Febrile Seizure): 10 mg/kg10\,mg/kg PO. Max 600 mg600\,mg.

IPRATROPIUM BROMIDE (Atrovent)

  • Class: Bronchodilator.
  • Dosing:
    • Adult: 0.5 mg0.5\,mg via Nebulizer (mixed with Albuterol).
    • Pediatric: 250 mcg250\,mcg via Nebulizer.

KETAMINE (Ketalar)

  • Class: Sedative, analgesic, dissociative anesthetic.
  • Indications: Excited delirium (4 mg/kg4\,mg/kg IM), RSI (2 mg/kg2\,mg/kg IV), Pain (0.3−0.5 mg/kg0.3-0.5\,mg/kg IV).

KETOROLAC (Toradol)

  • Class: NSAID.
  • Dosage (Adult 60 mg60\,mg IM or 30 mg30\,mg IV.

LABETALOL (Normodyne, Trandate)

  • Class: Beta Blocker.
  • Indications: Acute hypertensive crisis.
  • Dosage (Adult): 20 mg20\,mg IV over 2 minutes2\,minutes.

LIDOCAINE HCL (2%)

  • Class: Antidysrhythmic.
  • Cardiac Arrest Dosing: 1−1.5 mg/kg1-1.5\,mg/kg IV push. Repeat 0.75 mg/kg0.75\,mg/kg to max 3 mg/kg3\,mg/kg.
  • Maintenance: 2−4 mg/min2-4\,mg/min.
  • Geriatric Note: Reduce maintenance infusion by 50%50\% if over 70 years70\,years old.

LORAZEPAM (Ativan)

  • Class: Benzodiazepine.
  • Seizure Dosage (Adult): 2−4 mg2-4\,mg slow IV (2 mg/min2\,mg/min) or IM.
  • Note: IV doses must be diluted with equal volume of sterile water/saline.

MAGNESIUM SULFATE

  • Class: Electrolyte.
  • Eclampsia Seizure Dosing: 1−4 gm1-4\,gm IV over 10 minutes10\,minutes.
  • Torsades / Refractory VF Dosing: 1−2 gm1-2\,gm IV over 1−2 minutes1-2\,minutes.

MANNITOL 20%

  • Class: Osmotic diuretic.
  • Indications: Cerebral edema, ICP reduction.
  • Dosage: 0.50−2 g/kg0.50-2\,g/kg IV infusion over 15−30 minutes15-30\,minutes.
  • Instruction: Use in-line filter; can crystallize below 7.8 ∘C7.8\,^{\circ}C.

MORPHINE SULFATE

  • Class: Opioid analgesic.
  • Dosage (Adult): 0.1 mg/kg0.1\,mg/kg to a maximum of 10 mg10\,mg IV/IM/SC.
  • Counter-Agent: Naloxone must be available.

NALOXONE (Narcan)

  • Class: Narcotic antagonist.
  • Dosage (Adult): 0.4−2.0 mg0.4-2.0\,mg IV, IM, SC, or Nasal. Repeat every 5 min5\,min to 10 mg10\,mg max.
  • Dosage (Pediatric): 0.1 mg/kg0.1\,mg/kg to max 0.8 mg0.8\,mg.

NITROGLYCERIN

  • Class: Vasodilator.
  • Dosage: 0.3 mg0.3\,mg SL tablet or 0.4 mg0.4\,mg spray (max 33 doses).
  • Nitropaste: Apply 1 inch1\,inch (approx. 15 mg15\,mg) of 2%2\% ointment for CHF/PE/HTN.

NOREPINEPHRINE (Levophed)

  • Class: Vasopressor.
  • Dosage: 0.1−0.5 mcg/kg/min0.1-0.5\,mcg/kg/min titrated to 90 mmHg90\,mmHg systolic.
  • Caution: Tissue necrosis from extravasation.

ONDANSETRON (Zofran)

  • Class: Antiemetic.
  • Dosage (Adult): 4−8 mg4-8\,mg IV or PO.

OXYGEN

  • Flow Rates:
    • Cardiac Arrest/CO: 100%100\%.
    • Hypoxemia: 10−15 L/min10-15\,L/min (NRB).
    • COPD: 0−2 L/min0-2\,L/min (NC).

OXYTOCIN (Pitocin)

  • Class: Pituitary hormone, uterine vasoconstrictor.
  • Indication: Postpartum hemorrhage due to uterine atony.
  • Dosage: 10 units10\,units IM after placenta delivery; or 10−40 units10-40\,units in 1000 mL1000\,mL LR.

PANCURONIUM (Pavulon)

  • Class: Non-depolarizing neuromuscular blocker.
  • Dosage: 0.04−0.1 mg/kg0.04-0.1\,mg/kg slow IV.
  • Note: No effect on consciousness or pain.

PRALIDOXIME CHLORIDE (2-PAM)

  • Class: Cholinesterase reactivator.
  • Indication: Organophosphate poisoning.
  • Dosage: 1−2 grams1-2\,grams IV infusion in 100 ml100\,ml saline over 15−30 minutes15-30\,minutes.

PROCAINAMIDE (Pronestyl)

  • Class: Antidysrhythmic Class Ia.
  • Dosage (Adult): 20−30 mg/min20-30\,mg/min; max total 17 mg/kg17\,mg/kg. Maintenance: 1−4 mg/min1-4\,mg/min.

SODIUM BICARBONATE 8.4%

  • Class: Buffer, alkalinizer.
  • Dosage (Adult): 1 mEq/kg1\,mEq/kg IV; repeat 0.5 mEq/kg0.5\,mEq/kg every 10 min10\,min.

SUCCINYLCHOLINE (Anectine)

  • Class: Depolarizing skeletal muscle relaxant.
  • Dosage (Adult): 1−2 mg/kg1-2\,mg/kg rapid IV.
  • Onset: 1 minute1\,minute. Duration: 5−10 minutes5-10\,minutes.

TRANEXAMIC ACID (TXA)

  • Class: Hemostatic agent.
  • Indication: Hemodynamic compromise from trauma within 3 hours3\,hours of MOI.
  • Dosage: 1000 mg1000\,mg in 100 mL100\,mL NS infused over 10 minutes10\,minutes.

VASOPRESSIN (Pitressin)

  • Cardiac Arrest Dose: 40 units40\,units IV/IO push (replaces 1st or 2nd Epinephrine dose).

VERAPAMIL (Isoptin)

  • Class: Calcium channel blocker (Class IV antidysrhythmic).
  • Dosage: 2.5−5 mg2.5-5\,mg slow IV bolus over 2 min2\,min. Max 30 mg30\,mg.

ZIPRASIDONE (Geodon)

  • Class: Second-generation antipsychotic.
  • Dosage (Adult Chemical Restraint): 10 mg10\,mg IM.